CXCR4 and bacterial infectious disease: Interestingly, studies of WHIM (Warts, Hypogammaglobulinemia, recurrent bacterial Infections, and Myelokathexis) syndrome indicated that CXCR4 mutants, lacking the terminal 19 residues of the C-terminal tail which includes S339, do not have a decreased surface expression of the receptor [61].